Greenstone Announces the Introduction of Sirolimus Oral Solution
July 22, 2019

Dear Valued Customer,

Greenstone LLC is pleased to announce the availability of Sirolimus Oral Solution.

This product is the Authorized Generic of the innovator’s product, Rapamune®(sirolimus solution) and is manufactured under NDA# 21083, using the innovator’s process as registered under the NDA.

Click here for Full Prescribing Information, including Boxed Warning if applicable.

Rapamune® is a registered trademark.